1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil

• CAT Number: L028860
• CAS Number: 69123-94-0
• Molecular Formula: C9H11FN2O5
• Molecular Weight: 246.19
• Purity: ≥95%
• Target: Nucleoside Antimetabolite/Analog
• Storage: Store at 2-8°C
• IUPAC Name: 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
• InChI: InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8-/m1/s1
• InChIKey: UIYWFOZZIZEEKJ-PXBUCIJWSA-N
• SMILES: C1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F

1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil（Cat No.:L028860）is a modified nucleoside analog of uracil that incorporates a fluorine atom at the 2′ position of the sugar moiety. This structural modification enhances its stability and bioavailability, making it an intriguing candidate in antiviral and anticancer research. The compound can interfere with nucleic acid synthesis by mimicking natural nucleosides, potentially disrupting viral replication and tumor cell proliferation. Ongoing studies aim to evaluate its pharmacological properties, therapeutic efficacy, and mechanisms of action, positioning it as a promising agent in the development of targeted therapies.